Form 4 for CC Chemours Co
Accepted 2021-07-02 00:00:00 ET · period of report 2021-07-01 · accession 0001627223-21-000036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-02 | 2021-07-01 | CC | Newman Mark | Pres, CEO, Dir | A - Grant | $0.00 | +3,948 | 145.4K | +3% | $0 |
| D | 2021-07-02 | 2021-07-01 | CC | Newman Mark | Pres, CEO, Dir | A - Grant | $0.00 | +34.7K | 34.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-01 | A | A | 3,948 | $0.00 | 145,377.48 | D | — | — | (F1) Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2022. (F2) Includes directly owned shares, stock units and dividend equivalent units. |
| 2 | Derivative | Stock Option (Right to Buy) | 2021-07-01 | A | A | 34,696 | $0.00 | 34,696 | D | $35.46 · — to 2031-03-01 | 34,696 Common Stock | (F3) These options are scheduled to vest in three equal annual installments beginning on March 1, 2022. |